Navigation Links
OrthoAccel Technologies, Inc. Announces New Chief Financial Officer
Date:12/7/2011

HOUSTON, Dec. 7, 2011 /PRNewswire/ -- OrthoAccel Technologies, Inc., developers of the AcceleDent™ System, which is an acceleration device to enhance orthodontics, announced a new CFO, Andrew Layman, this week.  Mr. Layman began effective December 1, and will oversee all administrative and finance functions at OrthoAccel.

AcceleDent is a simple, removable and non-invasive appliance that a patient wears with braces or aligners in the mouth for 20 minutes daily to accelerate orthodontic tooth movement. The Company announced FDA clearance last month.  A randomized, controlled clinical trial conducted at the University of Texas Health Science Center at San Antonio demonstrated, with statistical significance, that tooth movement could be accelerated by 106% during the alignment phase and 38% to 50% during space closure.  There was no evidence of incremental root resorption or adverse events, thus demonstrating an excellent safety profile for the appliance.

Mr. Layman joins OrthoAccel as it prepares for its US market launch, amidst growing sales outside of the US.  He brings a diverse background that spans international finance, accounting, audit, and tax experience.  Mr. Layman is a CPA, and previously spent eight years at a "Big Four" public accounting firm.  His operating experience is broad, ranging from start-up to financial responsibility for a $3 billion division at Flextronics International, a leading electronics manufacturing services provider to the world's top technology brands.

Michael Lowe, CEO of OrthoAccel, commented, "We knew that 2012 would involve managing significant growth, and that it would be important to bring in an experienced finance executive."    Product availability to US doctors is scheduled for January 2012.  "We could not be more pleased with where the process led us.  Andy is a perfect fit in every way.  His track record for establishing risk management and internal controls will be an important part of our growth," Lowe continued. 

Mr. Layman remarked, "I am very pleased to join the management team at OrthoAccel during this exciting, rapid growth time."

Last month, in addition to FDA clearance, the Company announced a major partnership with a distributor in the Italy market.  Plans related to additional clinical trial activity with key university partners, both inside and outside of the US, are scheduled to be announced in the first quarter of 2012.

About OrthoAccel® Technologies, Inc.
Based in Houston, Texas, OrthoAccel® Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment. OrthoAccel currently sells its products in ten markets world-wide and received FDA clearance in November 2011 for the AcceleDent™ System. Product availability for US doctors is scheduled for January 2012.

About the AcceleDent™ System
AcceleDent™
represents the first clinical approach to accelerate orthodontic tooth movement via modulating bone biology. The appliance has been studied clinically as a complement to conventional fixed orthodontic appliances to apply gentle pulsing forces to the dentition to move teeth faster through accelerated bone remodeling. More information can be found at www.acceledent.com and www.acceledent.co.uk or requested via info@orthoaccel.com.


'/>"/>
SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction
2. OrthoAccel Technologies, Inc. Announces Definitive Distribution Agreements in Two Key Markets
3. OrthoAccel Technologies Announces Full-Market Release of AcceleDent, a New Technology to Shorten Treatment Time in Braces
4. OrthoAccel Technologies Committed to Plans for Positioning the United Kingdom as a Key Strategic Market for New Orthodontic Technology
5. Medical Device Industry Executive Joins OrthoAccel Technologies, Inc. Board of Directors
6. OrthoAccel Technologies, Inc. Announces New Scientific Advisor
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
10. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
11. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/18/2017)... Pa. and KALAMAZOO, Mich. , Sept. 18, ... , and OptiMed Specialty Pharmacy of ... to offer a strategic hub service that expedites and ... sought-after personal spirometer, Spiro PD 2.0, and wellness management ... spirometer is a medical device used to measure lung ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
Breaking Medicine News(10 mins):